Bioprocessing Market Size, Share, Growth, and Industry Analysis, By Type (Cell Expansion, Cell Culture, Cell Line Development, Flow Cytometry, Virus Infiltration), By Application (Specialty Products, Biopharmaceuticals, Environment Management, Industrial Chemicals), Regional Insights, and Forecast To 2032

• 

   Request a Free Sample To Get More Information on this Market

BIOPROCESSING MARKET REPORT OVERVIEW

The global bioprocessing market size was USD 39.85 billion in 2023 and the market is projected to touch USD 93.68 billion by 2032 at a CAGR of 9.96% during the forecast period.

Numerous bioprocessing procedures utilize single-use media bags and containers. Additionally, single-use containers are frequently employed in the biopharmaceutical and bio manufacturing sectors for crucial liquid handling applications. Additionally, monoclonal antibodies (mAb) are produced using bioprocessing technologies; as a result, this sector dominates the worldwide bioprocessing market.

Bioprocessing technology has grown more popular as a result of rising biopharmaceutical demand over the past several years and rising funding for the research and production of biologics such monoclonal antibodies, immunizations recombinant proteins, and others. The adoption of single-use systems throughout the bioprocessing industry has also been aided by benefits related to their use, such as the large decrease in costs and time needed for operations and facility building.

COVID-19 Impact: Utilization of Single-Use Technology to Advance Market Share

Due to the large drop in manufacturing procedures and the constrained demand and supply of medications, the early stages of the pandemic had a severe negative impact on the expansion in the bioprocessing business. But single-use technology (SUT), which includes preclinical and clinical scales, has emerged as a key innovation in pre-commercial manufacturing. As COVID-19 instances multiplied, so did the need for multiple vaccinations and efficient medications. Due to a lower probability of contamination and fewer sterilizing checks between batches, single-use processing equipment and methods from biopharmaceutical businesses were also more widely adopted. Additionally, finding new drugs employing technologies that are only used once became a top priority for controlling the pandemic.

The majority of COVID-19 vaccine development is centered on single-use technology as a result of the elevated infection rates. Thus, these initiatives make use of cutting-edge techniques including mRNA and DNA technology. As a result, the bioprocessing market share under investigation saw notable development during the COVID-19 outbreak.

LATEST TRENDS

"Ongoing Product Improvements to Stimulate Market Development "

Due to ongoing product improvements and the growing importance of bio-processing proceduresteps throughout the whole production process, the simple and peripheral elements category achieved the greatest market sharewithin 2022. The simple and peripheral elements segment was dominated by tubing, filters, interfaces, and transfer systems since most single-use vendors offer tubing and connections in a format that is compatible with disposable bags, bioreactors, or similar single-use processing equipment. For example, the company Thermo Fisher Scientific, Inc. provides customization options for their bio-processing container bag and other processing equipment, allowing users to add tubing and connectors. These elements are anticipated to propel the bioprocessing market growth.

BIOPROCESSING MARKET SEGMENTATION

• By Type

Based on type; the market is divided into cell expansion, cell culture, cell line development, flow cytometry, virus infiltration

Cell expansion is the leading part of the type segment.

• By Application

Based on the application; the market is divided into specialty products, biopharmaceuticals, environment management, industrial chemicals

Specialty products is the leading part of the application segment.

DRIVING FACTORS

"Employment in Biopharmaceutical Segment to Aid Market Expansion "

Over the course of the forecast period, the market biopharmaceutical segment is anticipated to expand considerably. It is brought on by the increased usage concerning single-use technologies and mechanisms, the rise in demand for biologics, and expanding business operations. Additionally, the biopharmaceutical industry is adopting single-use products and technologies more frequently due to some of their benefits over conventional bio procedure approaches including lower initial expenditures and research and development expenses, low costs for labor and supplies, and ease of disposal. In addition, these facilities are widely used by the company and provide higher-quality carbon dioxide (CO2) equilibrium than stainless steel reactors utilized for conventional bio-processing.

"Rising Incidence of Chronic Diseases to Foster Industry Progress "

The market is expanding as a result of the rising incidence of chronic diseases including cancer and diabetes as well as the demand for better, more individualized treatments. The need for biotechnology-derived treatments is rising as a result of this. Furthermore, the development of novel bio-processing methods including single-use technology and continuous manufacturing has made it feasible to make these goods in a more affordable and environmentally friendly manner, which is in turn promoting the market's expansion.

RESTRAINING FACTORS

"Tight Regulations Related to the Utilization of Systems to Stop Market Evolution "

However, certain problems including as extractability along with leach ability difficulties will hamper the market. Additionally, tight regulations related to utilization of disposable systems within biopharmaceutical industry impede the market growth.

• 

   Request a Free Sample To Get Analysis on Major Geographic Market

BIOPROCESSING MARKET REGIONAL INSIGHTS

"North America to Support Market Advancement owing to Medical Services and Facilities "

Given the ongoing pattern of launching breakthroughbio-processing devices within developed economies including the U.S. and Canada before making them public to the rest of the globe, North America dominated the global market in 2020. The medical services and facilities in North America are well-known. The market has expanded as a result of the increased usage of techniques for a variety of biopharmaceutical applications. However, due to the large demand for bioprocess equipment, such as laboratories filtration systems as well as membrane-based microbiological analysis, among many other things, the market is anticipated to have significant expansion.

The pharma along with laboratory equipment markets both experienced significant expansion in the North American region, which is anticipated to present profitable prospects for one-use bio-processing items in the future.

KEY INDUSTRY PLAYERS

"Key Players Focus on Partnerships to Gain a Competitive Advantage"

Prominent market players are making collaborative efforts by partnering with other companies to stay ahead of the competition. Many companies are also investing in new product launches to expand their product portfolio. Mergers and acquisitions are also among the key strategies used by players to expand their product portfolios.

The analyst provides a comprehensive picture of the market through the study, synthesis, and summarization of data from various sources, as well as an examination of important variables such as financial gain, sales prices, competition, and promotions. It identifies the key industry influencers and presents various market facets. The information provided is thorough, reliable, and the result of extensive primary and secondary research. Themarket report provides a comprehensive competitive landscape as well as an in-depth vendor evaluation methodology and analysis based on both qualitative and quantitative studies to accurately forecast market growth.

The reports cover important advances with in market, as well as inorganic and organic growth strategies. Various companies are concentrating on organic business expansion such as product announcements, product approvals, and other things like patents and events. Acquisitions, partnerships, and collaborations were among the inorganic growth strategies observed in the market. The above activities have paved the way for market participants to expand their business and customer base. With the growing demands for filter products in the international market, market participants in the market areexpected to benefit from substantial growth opportunities in the near future.

List of Top Bioprocessing Companies

• HyClone (GE Healthcare) (U.S.)
• Finesse Solutions (Thermo Fisher) (U.S.)
• Zeta Holding (U.S.)
• Repligen (U.S.)
• Asahi Kasei (Japan)
• BD Biosciences (U.S.)
• GE Healthcare (U.S.)
• DHR (Pall, Danaher) (U.S.)
• Eppendorf (Germany)
• Bio-Rad (U.S.)
• Infors HT (Switzerland)
• Pierre Guerin Technologies (France)
• Sartorius (Germany)
• Merck KGaA (Germany)

REPORT COVERAGE

This research offers a thorough analysis of the global market, covering all relevant areas. This includes everything from a broad market overview to micro-level information about size of the market, degree of competition, evolutiontrend, opportunities in themarket, important market drivers, and SWOTopportunities and threats. The reader can use the study to influence industry competitiveness and competitive environment strategies to increase potential profit. Additionally, it offers a straightforward framework for assessing and gaining access to the situation of the corporate organization.

In a nutshell, this study should be read by all market participants, traders, academics, analysts, business planners, and anyone else with an interest in the market. The market competitive landscape is another area that the report structure focuses on. This report presents in depth information the share of the market, macroeconomic indicators, product scenario, operation circumstances of the major players, which aids readers in the industry in recognizing the key rivals and better understanding the market's competitive landscape.